Table 2 Details of disease status for five PsA patients analyzed in Table 3 and Figure 4(b) at the time of sample collection
From: CD16 (FcRγIII) as a potential marker of osteoclast precursors in psoriatic arthritis
Patient number | Age | Gender | % BSA | Joint count |
|---|---|---|---|---|
4 | 38 | M | 2% | 9 T, S jts, 2 DD |
5 | 40 | F | 4% | 9 T, S jts, 2 DD |
6 | 45 | M | 15% | 4 T, S jts severe AD |
7 | 27 | M | 80% | 6 T, S jts |
8 | 26 | F | 2% | 8 T, S jts |